Tearsheet

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11%

Low stock price volatility
Vol 12M is 27%

Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care.

Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 25x, P/EPrice/Earnings or Price/(Net Income) is 33x

Key risks
ENSG key risks include [1] its heavy reliance on government reimbursement, Show more.

0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11%
1 Low stock price volatility
Vol 12M is 27%
2 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care.
3 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 25x, P/EPrice/Earnings or Price/(Net Income) is 33x
4 Key risks
ENSG key risks include [1] its heavy reliance on government reimbursement, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Ensign (ENSG) stock has gained about 15% since 12/31/2025 because of the following key factors:

1. Strong Q4 2025 Earnings Beat and Optimistic 2026 Guidance.

The Ensign Group reported adjusted earnings per share (EPS) of $1.82 for Q4 2025 on February 4, 2026, surpassing analysts' consensus estimates of $1.75 by $0.07, or 4%. Despite a slight revenue miss, investor focus shifted to the company's robust 2026 full-year guidance, which projected a midpoint revenue of $5.81 billion (1.7% above forecasts) and EPS of $7.51 per share (9.4% above expectations). This guidance indicated a 14.3% increase over 2025 results at the midpoint.

2. Significant Operational Momentum and Occupancy Gains.

The company demonstrated broad-based operational strength, with same-store and transitioning facility occupancy rates reaching record highs of 83.8% and 84.9%, respectively. Overall, total occupancy increased by 2.8% to 83.2%. Additionally, Medicare revenue for the quarter improved significantly by 15.7% year-over-year.

Show more

Stock Movement Drivers

Fundamental Drivers

The 14.3% change in ENSG stock from 12/31/2025 to 4/10/2026 was primarily driven by a 9.4% change in the company's P/E Multiple.
(LTM values as of)123120254102026Change
Stock Price ($)174.14199.0214.3%
Change Contribution By: 
Total Revenues ($ Mil)4,8295,0584.7%
Net Income Margin (%)6.8%6.8%0.1%
P/E Multiple30.433.39.4%
Shares Outstanding (Mil)5758-0.3%
Cumulative Contribution14.3%

LTM = Last Twelve Months as of date shown

Market Drivers

12/31/2025 to 4/10/2026
ReturnCorrelation
ENSG14.3% 
Market (SPY)-5.4%1.0%
Sector (XLV)-4.8%19.1%

Fundamental Drivers

The 15.3% change in ENSG stock from 9/30/2025 to 4/10/2026 was primarily driven by a 9.6% change in the company's Total Revenues ($ Mil).
(LTM values as of)93020254102026Change
Stock Price ($)172.65199.0215.3%
Change Contribution By: 
Total Revenues ($ Mil)4,6155,0589.6%
Net Income Margin (%)7.0%6.8%-2.8%
P/E Multiple30.633.39.0%
Shares Outstanding (Mil)5758-0.7%
Cumulative Contribution15.3%

LTM = Last Twelve Months as of date shown

Market Drivers

9/30/2025 to 4/10/2026
ReturnCorrelation
ENSG15.3% 
Market (SPY)-2.9%10.9%
Sector (XLV)6.3%24.1%

Fundamental Drivers

The 54.0% change in ENSG stock from 3/31/2025 to 4/10/2026 was primarily driven by a 34.9% change in the company's P/E Multiple.
(LTM values as of)33120254102026Change
Stock Price ($)129.21199.0254.0%
Change Contribution By: 
Total Revenues ($ Mil)4,2605,05818.7%
Net Income Margin (%)7.0%6.8%-2.8%
P/E Multiple24.733.334.9%
Shares Outstanding (Mil)5758-1.1%
Cumulative Contribution54.0%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2025 to 4/10/2026
ReturnCorrelation
ENSG54.0% 
Market (SPY)16.3%30.6%
Sector (XLV)2.3%35.8%

Fundamental Drivers

The 109.5% change in ENSG stock from 3/31/2023 to 4/10/2026 was primarily driven by a 67.2% change in the company's Total Revenues ($ Mil).
(LTM values as of)33120234102026Change
Stock Price ($)95.01199.02109.5%
Change Contribution By: 
Total Revenues ($ Mil)3,0255,05867.2%
Net Income Margin (%)7.4%6.8%-8.4%
P/E Multiple23.333.343.0%
Shares Outstanding (Mil)5558-4.3%
Cumulative Contribution109.5%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2023 to 4/10/2026
ReturnCorrelation
ENSG109.5% 
Market (SPY)63.3%28.2%
Sector (XLV)19.1%38.8%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
ENSG Return15%13%19%19%31%16%180%
Peers Return39%2%18%13%21%21%177%
S&P 500 Return27%-19%24%23%16%-0%82%

Monthly Win Rates [3]
ENSG Win Rate50%58%67%58%67%50% 
Peers Win Rate63%53%57%53%62%55% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
ENSG Max Drawdown-5%-15%-8%0%-10%-2% 
Peers Max Drawdown-6%-31%-10%-11%-20%-9% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-7% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: ACHC, HCA, THC, ENSG, UHS.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/10/2026 (YTD)

How Low Can It Go

Unique KeyEventENSGS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-28.0%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven38.8%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven420 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-53.1%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven113.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven143 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-35.3%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven54.6%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven391 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-54.8%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven121.4%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven160 days1,480 days

Compare to ACHC, HCA, THC, ENSG, UHS

In The Past

Ensign's stock fell -28.0% during the 2022 Inflation Shock from a high on 3/26/2021. A -28.0% loss requires a 38.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Ensign (ENSG)

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

AI Analysis | Feedback

Here are 1-2 brief analogies for Ensign (ENSG):

  • It's like a Marriott or Hilton chain, but instead of hotels, they operate skilled nursing homes and senior living facilities.
  • Think of it as an HCA Healthcare (a large hospital operator) that specializes in skilled nursing, rehabilitation, and senior living facilities.

AI Analysis | Feedback

  • Skilled Nursing Care: Provides short and long-term nursing care for patients with chronic conditions, prolonged illness, and the elderly.
  • Rehabilitative Therapies: Offers physical, occupational, and speech therapies and other rehabilitative healthcare services.
  • Senior Living Management: Manages senior living facilities, providing room and board, nutritional programs, and social and recreational services.
  • Mobile Diagnostic & Ancillary Services: Delivers digital x-ray, ultrasound, electrocardiogram, laboratory, and patient transportation services.
  • Real Estate Leasing: Engages in leasing real estate properties, primarily healthcare facilities.

AI Analysis | Feedback

Ensign (symbol: ENSG) sells primarily to individuals. The company serves the following categories of customers:

  1. Elderly individuals and patients with chronic conditions or prolonged illnesses: These customers utilize Ensign's short and long-term nursing care services, skilled nursing, and other related support services provided within its healthcare facilities.
  2. Patients requiring rehabilitative care: This category includes individuals recovering from illness, injury, or surgery who need physical, occupational, or speech therapies to regain function and independence.
  3. Senior living residents: Individuals who reside in Ensign's senior living communities, benefiting from a range of services including room and board, social programs, and assistance with daily living.

AI Analysis | Feedback

null

AI Analysis | Feedback

```html

Barry Port, Chief Executive Officer and Chairman of the Board

Barry Port has served as Chief Executive Officer and a Board Member since May 2019 and was appointed Chairman of the Board in September 2025. Prior to his CEO role, he was Chief Operating Officer of Ensign Services, Inc. from 2012 to 2019. From 2006 to 2011, he served as President of Keystone Care, Inc., overseeing facilities in Texas. His healthcare leadership career began with operational roles directing skilled nursing campuses in Arizona and Texas.

Suzanne D. Snapper, Chief Financial Officer, Executive Vice President and Director

Suzanne D. Snapper has served as Chief Financial Officer since August 2009, having joined Ensign in April 2007. She played a pivotal role as CFO in the successful spin-offs of Care Trust REIT in 2014 and The Pennant Group in 2019, and contributed significantly to the formation of the Standard Bearer REIT in 2022. Before joining Ensign, Ms. Snapper spent ten years as a senior manager at KPMG LLP, where she provided audit services for public companies.

Spencer Burton, President & Chief Operating Officer

Spencer Burton was appointed President and Chief Operations Officer on May 30, 2019. He has nearly 20 years of experience in post-acute care and previously served as President of Pennant Healthcare, Inc., a Northwest-based portfolio company of Ensign Services. Mr. Burton also held leadership roles as Executive Director at affiliated operations in California, Texas, and Washington.

Chad A. Keetch, Chief Investment Officer, Executive Vice President & Secretary

Chad A. Keetch assumed the roles of Chief Investment Officer, Executive Vice President, and Secretary on May 30, 2019. He oversees business development, strategic growth, capital markets activities, new business ventures, and the management of the company's real estate portfolio. Mr. Keetch was instrumental in the spin-off of Care Trust REIT, Inc. in 2014 and The Pennant Group, Inc. in 2019. Prior to joining Ensign, he was a transactional attorney at Stoel Rives LLP (2008-2010) and Kirkland & Ellis LLP (2005-2008), where his practice focused on private equity, mergers and acquisitions, leveraged buyouts, and capital markets transactions.

Beverly B. Wittekind, Vice President and General Counsel

Beverly B. Wittekind serves as Vice President and General Counsel for The Ensign Group, Inc. She also holds the title of Chief Legal Officer for Ensign Services, Inc., where she provides strategic counsel in areas such as risk management, litigation, regulatory compliance, employment law, and dispute resolution. Ms. Wittekind joined Ensign in November 2009.

```

AI Analysis | Feedback

The Ensign Group, Inc. (ENSG) faces several key risks inherent in the post-acute care continuum and skilled nursing facility industry.

  1. Reimbursement Rate Fluctuations and Government Regulation: Changes in government reimbursement policies, particularly for Medicare and Medicaid, represent a primary risk to Ensign Group's revenue streams and financial viability. These changes can include reductions in rates, shifts in state budgets, and the expiration of specific funding programs, such as a California program slated to end after 2026. The company's financial performance is closely linked to these policies, and reductions in reimbursement or delays in payments can materially and adversely affect its operations. Compliance with evolving regulations, including models like the Patient-Driven Payment Model (PDPM), also poses a significant risk.
  2. Labor Shortages and Rising Costs: The healthcare industry, especially the skilled nursing sector, faces persistent labor shortages, wage inflation, and demanding workloads. This workforce crisis, exacerbated by factors like burnout and low wages, contributes to increased operating costs for Ensign Group and can compromise the quality of resident care. The difficulty in recruiting and retaining qualified staff can lead to higher rates of infections, falls, and hospital readmissions, further impacting the business.
  3. Integration of Acquisitions and Competitive Landscape: Ensign Group's growth strategy heavily relies on acquiring and integrating new healthcare facilities. Successfully integrating these newly acquired operations, particularly large portfolios across multiple states, presents a significant challenge. Delays or inefficiencies in this integration process can hinder the realization of expected returns and impact operational performance. Furthermore, the company faces intense competition from other healthcare entities in acquiring, developing, and operating facilities, which can drive up acquisition costs and affect market share.

AI Analysis | Feedback

The accelerating shift towards comprehensive home-based care models, enabled by advancements in telehealth and remote patient monitoring technologies, poses a clear emerging threat. This trend allows for more complex post-acute and rehabilitative care, traditionally provided in skilled nursing facilities or senior living centers, to be delivered effectively and safely in patients' homes. As patient preference and technological capabilities drive this evolution in healthcare delivery, the demand for Ensign's facility-based services could diminish.

AI Analysis | Feedback

Ensign (symbol: ENSG) operates within several significant addressable markets within the U.S. healthcare services sector. These markets include skilled nursing facilities, the broader post-acute care continuum, senior living, and mobile diagnostics services. All market sizes are for the U.S. region.

Skilled Nursing Facilities Market

The U.S. skilled nursing facility market was valued at approximately USD 254.95 billion in 2025 and is projected to reach around USD 388.42 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.3% from 2026 to 2035. Other estimates place the market size at USD 199.72 billion in 2024, with projections to reach USD 290.02 billion by 2033 at a CAGR of 4.39% from 2025 to 2033. Another source indicated a value of USD 202.4 billion in 2025, anticipated to grow to USD 279.9 billion by 2035. A more conservative estimate for the skilled nursing facility segment of the total U.S. post-acute care market in 2025 was approximately USD 130 billion.

Post-Acute Care Market

The U.S. post-acute care (PAC) market, which encompasses skilled nursing, home care, long-term acute care, and inpatient rehabilitation, demonstrates a substantial addressable market. This market was valued at approximately USD 507.12 billion in 2025 and is predicted to increase to around USD 822.98 billion by 2035, exhibiting a CAGR of 4.96% from 2026 to 2035. Other estimates for the U.S. post-acute care market size in 2025 include USD 490.6 billion, with a projection to reach USD 898.5 billion by 2035 at a CAGR of 6.4% from 2026 to 2035. Another report valued the market at USD 461.38 billion in 2025, expecting it to reach approximately USD 766.71 billion by 2035, growing at a CAGR of 5.21% from 2026 to 2035.

Senior Living Market

The U.S. senior living market size was valued at USD 943.90 billion in 2025 and is expected to reach USD 1.33 trillion by 2033, growing at a CAGR of 4.47% from 2026 to 2033. Another report estimated the market size at USD 923.75 billion in 2023, with a projection to reach approximately USD 1,391.23 billion by 2033, demonstrating a CAGR of 4.18% during the forecast period from 2024 to 2033.

Mobile Diagnostics Services Market

The U.S. mobile imaging services market, which includes digital x-ray, ultrasound, and EKG services as provided by Ensign, was valued at USD 5.3 billion in 2022. More specifically for mobile MRI services, the U.S. market size was estimated at USD 3.99 billion in 2025 and is projected to reach around USD 5.67 billion by 2035, with a CAGR of 3.58% from 2026 to 2035. Another report indicated the U.S. mobile MRI services market size was estimated at USD 3.67 billion in 2024.

AI Analysis | Feedback

The Ensign Group, Inc. (ENSG) is expected to drive future revenue growth over the next 2-3 years through several key strategies:
  1. Strategic Acquisitions and Portfolio Expansion: Ensign Group consistently expands its portfolio by acquiring skilled nursing and post-acute care facilities. The company often targets facilities with turnaround potential or long-term value, integrating them into its decentralized operating model. For instance, the company acquired 45 new operations in 2025 and added 52 new operations since the beginning of 2024, expanding its footprint across various states. This acquisition-driven growth is a core part of its strategy, with management's 2026 guidance assuming continued acquisition activity.
  2. Organic Growth through Enhanced Occupancy and Patient Mix: The company focuses on improving occupancy rates and attracting a higher-acuity patient mix (Medicare and managed care). Ensign has demonstrated strong organic growth, with same-facilities occupancy improving and transitioning-facilities occupancy increasing year-over-year. This improvement in occupancy, coupled with an increased number of skilled patient days and higher Medicare and managed care revenues, significantly contributes to revenue growth. Management believes significant organic growth potential remains, as many facilities have yet to reach peak occupancy levels.
  3. Expansion and Optimization of Service Offerings: Ensign Group's revenue expansion is driven by increasing service offerings in skilled nursing, rehabilitation, and senior living. The growing elderly population in the U.S. continues to fuel demand for these services, supporting Ensign's long-term outlook. The company's ability to offer advanced healthcare services, particularly rehabilitation, is anticipated to contribute significantly to the revenue growth of its Skilled Services segment.
  4. Strategic Real Estate Investments via Standard Bearer Healthcare REIT: Through its captive real estate investment trust (REIT), Standard Bearer Healthcare REIT, Inc., Ensign acquires and owns underlying real estate assets. This strategy provides both operational and real estate investment returns, with Standard Bearer capturing real estate value and contributing to financial stability through consistent rental income. The Standard Bearer segment saw a 33.9% increase in funds from operations in Q4 2025.
  5. Favorable Pricing and Reimbursement Trends: Ensign has benefited from price increases, as evidenced by its revenue growth outpacing the growth in units sold over the past two years. The company has also shown substantial year-over-year growth in same-store Medicare revenue and managed care revenue, indicating improved reimbursement rates for its skilled services. The ability of local partners to build clinical capabilities helps attract a higher-quality patient population with better reimbursement prospects.

AI Analysis | Feedback

Share Repurchases

  • The Ensign Group repurchased shares worth $20 million in 2025.
  • As of September 30, 2024, the company did not make any purchases under its stock repurchase program.

Share Issuance

  • Ensign's shares outstanding for the quarter ending December 31, 2025, were 0.059 billion, representing a 1.09% increase year-over-year.
  • Shares outstanding increased by 1.09% in 2025 from 2024, and by 1.6% in 2024 from 2023.

Outbound Investments

  • In 2025, The Ensign Group completed 51 acquisitions, including 12 real estate assets.
  • Effective December 1, 2025, the company acquired the operations of four skilled nursing facilities in Colorado, Kansas, and Arizona.
  • The Ensign Group acquired operations of Agave Grove Post Acute and four other skilled nursing facilities, as well as real estate in Texas and Wisconsin, effective February 1, 2026.

Capital Expenditures

  • Accrued capital expenditures were $7.3 million for the nine months ended September 30, 2024, and $4.1 million for the same period in 2023.
  • Capital investments are primarily focused on upgrading facilities, adding beds, and developing new healthcare infrastructure.
  • A strategic focus for capital expenditures includes acquiring newer assets and improving existing physical plants to enhance care quality and census rates.

Better Bets vs. Ensign (ENSG)

Trade Ideas

Select ideas related to ENSG.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
PGNY_3312026_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG03312026PGNYProgynyDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
0.0%0.0%0.0%
CNC_3272026_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG03272026CNCCenteneDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
2.3%2.3%-0.6%
OSCR_3272026_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG03272026OSCROscar HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.0%3.0%-2.6%
WAT_3202026_Monopoly_xInd_xCD_Getting_Cheaper03202026WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
-0.4%-0.4%-3.3%
GILD_3202026_Quality_Momentum_RoomToRun_10%03202026GILDGilead SciencesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
1.6%1.6%-2.2%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

ENSGACHCHCATHCUHSMedian
NameEnsign Acadia H.HCA Heal.Tenet He.Universa. 
Mkt Price199.0225.94495.47195.24180.78195.24
Mkt Cap11.52.3112.417.011.211.5
Rev LTM5,0583,31375,60021,31017,36517,365
Op Inc LTM42538811,9653,4391,9941,994
FCF LTM180-4407,6922,530825825
FCF 3Y Avg185-3216,0061,756824824
CFO LTM56413212,6363,5401,8641,864
CFO 3Y Avg42924110,8602,6541,7331,733

Growth & Margins

ENSGACHCHCATHCUHSMedian
NameEnsign Acadia H.HCA Heal.Tenet He.Universa. 
Rev Chg LTM18.7%5.0%7.1%3.1%9.7%7.1%
Rev Chg 3Y Avg18.7%8.3%7.9%3.6%9.0%8.3%
Rev Chg Q20.2%6.1%6.7%8.9%9.1%8.9%
QoQ Delta Rev Chg LTM4.7%1.4%1.7%2.2%2.2%2.2%
Op Mgn LTM8.4%11.7%15.8%16.1%11.5%11.7%
Op Mgn 3Y Avg7.9%15.3%15.2%14.0%10.1%14.0%
QoQ Delta Op Mgn LTM0.1%-1.9%0.2%0.1%0.0%0.1%
CFO/Rev LTM11.2%4.0%16.7%16.6%10.7%11.2%
CFO/Rev 3Y Avg9.8%8.0%15.4%12.7%10.9%10.9%
FCF/Rev LTM3.6%-13.3%10.2%11.9%4.7%4.7%
FCF/Rev 3Y Avg4.4%-9.9%8.5%8.4%5.2%5.2%

Valuation

ENSGACHCHCATHCUHSMedian
NameEnsign Acadia H.HCA Heal.Tenet He.Universa. 
Mkt Cap11.52.3112.417.011.211.5
P/S2.30.71.50.80.60.8
P/EBIT24.7-2.59.34.75.35.3
P/E33.3-2.116.612.17.512.1
P/CFO20.317.88.94.86.08.9
Total Yield3.1%-47.0%6.6%8.3%13.7%6.6%
Dividend Yield0.1%0.0%0.6%0.0%0.5%0.1%
FCF Yield 3Y Avg2.5%-16.4%7.1%15.1%6.9%6.9%
D/E0.21.10.40.80.50.5
Net D/E0.11.10.40.60.40.4

Returns

ENSGACHCHCATHCUHSMedian
NameEnsign Acadia H.HCA Heal.Tenet He.Universa. 
1M Rtn-5.4%8.6%-7.8%-16.8%-2.9%-5.4%
3M Rtn14.5%91.7%5.1%-3.0%-12.6%5.1%
6M Rtn13.6%6.9%19.7%3.0%-7.7%6.9%
12M Rtn56.1%-4.2%48.9%53.1%1.8%48.9%
3Y Rtn101.9%-65.1%86.8%214.1%38.3%86.8%
1M Excs Rtn-6.0%8.0%-8.4%-17.4%-3.5%-6.0%
3M Excs Rtn14.5%94.4%5.1%-2.5%-12.8%5.1%
6M Excs Rtn12.0%0.4%15.6%-3.5%-12.7%0.4%
12M Excs Rtn24.3%-41.2%13.4%26.6%-32.1%13.4%
3Y Excs Rtn44.8%-130.0%23.6%167.5%-23.5%23.6%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Skilled Services4,0773,5792,9062,5232,288
All other revenue19315612310399
Standard Bearer95827358 
Elimination of intercompany revenue-104-88-76-57-46
Real Estate    61
Total4,2603,7293,0252,6272,403


Price Behavior

Price Behavior
Market Price$199.02 
Market Cap ($ Bil)11.5 
First Trading Date11/09/2007 
Distance from 52W High-7.8% 
   50 Days200 Days
DMA Price$202.94$178.12
DMA Trendupup
Distance from DMA-1.9%11.7%
 3M1YR
Volatility35.8%26.8%
Downside Capture-0.150.13
Upside Capture56.0170.63
Correlation (SPY)-1.5%26.3%
ENSG Betas & Captures as of 3/31/2026

 1M2M3M6M1Y3Y
Beta0.74-0.090.050.250.450.46
Up Beta0.040.360.140.710.550.46
Down Beta0.65-0.13-0.160.010.270.33
Up Capture78%54%58%46%59%33%
Bmk +ve Days7162765139424
Stock +ve Days9223161135393
Down Capture88%-75%-23%6%34%68%
Bmk -ve Days12233358110323
Stock -ve Days13203265116357

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ENSG
ENSG61.4%27.1%1.74-
Sector ETF (XLV)12.3%16.8%0.5234.0%
Equity (SPY)31.2%17.3%1.4730.3%
Gold (GLD)60.1%27.8%1.69-5.4%
Commodities (DBC)29.8%16.6%1.58-5.8%
Real Estate (VNQ)21.3%15.2%1.0732.6%
Bitcoin (BTCUSD)-5.7%43.7%-0.01-9.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ENSG
ENSG16.4%26.4%0.57-
Sector ETF (XLV)6.3%14.6%0.2540.5%
Equity (SPY)11.1%17.0%0.5037.8%
Gold (GLD)22.1%17.8%1.026.6%
Commodities (DBC)11.8%18.8%0.525.3%
Real Estate (VNQ)3.7%18.8%0.1042.2%
Bitcoin (BTCUSD)4.0%56.5%0.299.7%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ENSG
ENSG25.4%36.0%0.73-
Sector ETF (XLV)9.8%16.5%0.4846.7%
Equity (SPY)13.8%17.9%0.6647.7%
Gold (GLD)14.2%15.9%0.743.5%
Commodities (DBC)8.6%17.6%0.4116.7%
Real Estate (VNQ)5.1%20.7%0.2245.4%
Bitcoin (BTCUSD)67.4%66.9%1.0713.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date3312026
Short Interest: Shares Quantity1.4 Mil
Short Interest: % Change Since 315202620.9%
Average Daily Volume0.4 Mil
Days-to-Cover Short Interest3.7 days
Basic Shares Quantity57.6 Mil
Short % of Basic Shares2.5%

Returns Analyses

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
2/4/202613.8%22.4%19.7%
11/3/20250.1%-1.3%-3.2%
7/24/20258.9%8.9%25.2%
4/29/20250.7%4.2%14.4%
2/5/2025-8.7%-15.3%-12.4%
10/24/20242.7%4.1%-1.7%
7/25/20244.9%2.5%8.7%
5/1/2024-2.4%-2.8%1.5%
...
SUMMARY STATS   
# Positive141516
# Negative1098
Median Positive5.1%7.9%12.7%
Median Negative-2.5%-3.5%-5.8%
Max Positive15.0%22.4%26.4%
Max Negative-8.7%-15.3%-12.4%

SEC Filings

Expand for More
Report DateFiling DateFiling
12/31/202502/04/202610-K
09/30/202511/03/202510-Q
06/30/202507/24/202510-Q
03/31/202504/29/202510-Q
12/31/202402/05/202510-K
09/30/202410/24/202410-Q
06/30/202407/25/202410-Q
03/31/202405/01/202410-Q
12/31/202302/01/202410-K
09/30/202310/25/202310-Q
06/30/202307/27/202310-Q
03/31/202304/26/202310-Q
12/31/202202/02/202310-K
09/30/202210/26/202210-Q
06/30/202208/01/202210-Q
03/31/202204/28/202210-Q

Recent Forward Guidance [BETA]

Latest: Q4 2025 Earnings Reported 2/4/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue5.77 Bil5.80 Bil5.84 Bil14.7% RaisedGuidance: 5.06 Bil for 2025
2026 EPS7.417.517.6115.4% RaisedGuidance: 6.51 for 2025

Prior: Q3 2025 Earnings Reported 11/3/2025

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2025 Annual Earnings Per Share6.486.516.541.7% RaisedGuidance: 6.4 for 2025
2025 Annual Revenue5.05 Bil5.06 Bil5.07 Bil1.1% RaisedGuidance: 5.00 Bil for 2025

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Smith, Barry M DirectSell1062026173.59700121,5134,105,751Form
2Wittekind, Beverly BVP and Chief Legal OfficerDirectSell12232025180.002,000360,0005,900,220Form
3Wittekind, Beverly BVP and Chief Legal OfficerDirectSell12162025175.488,4001,474,0005,751,933Form
4Smith, Barry M DirectSell12032025184.27700128,9894,487,343Form
5Burton, SpencerPresident and COODirectSell11242025180.003,690664,2009,209,700Form